Tara S. Barton‐Maclaren

Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence

Richard A. Becker, Gerald T. Ankley, Stephen W. Edwards et al. · Regulatory Toxicology and Pharmacology · 2015 · 259 citations · Full text

Pharmacy, Risk Management, Evidence-based Practice +15

Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization

Katie Paul Friedman, Matthew Gagné, Lit‐Hsin Loo et al. · Toxicological Sciences · 2019 · 245 citations · Full text

Pharmacy, Toxicology, Environmental Toxicology +16

Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment

Reza Farmahin, Andrew Williams, Byron Kuo et al. · Archives of Toxicology · 2016 · 191 citations · Full text

Pharmacy, Toxicology, Molecular Toxicology +16

Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients

Matthew Dent, Eric Vaillancourt, Russell S. Thomas et al. · Regulatory Toxicology and Pharmacology · 2021 · 98 citations · Full text

Agriculture, Food Science, Risk Management +14

A Transformative Vision for an Omics-Based Regulatory Chemical Testing Paradigm

Kamin J. Johnson, Scott S. Auerbach, Tina Stevens et al. · Toxicological Sciences · 2022 · 90 citations · Full text

Pharmacy, Molecular Biology, Toxicology +17